Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
about
Nitric oxide and peroxynitrite in health and diseaseRole of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategiesProtein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its ComplicationsLutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye DiseaseHyperglycemic Stress and Carbon Stress in Diabetic GlucotoxicityInterplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathySources and implications of NADH/NAD(+) redox imbalance in diabetes and its complicationsPathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP)PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's DiseaseS-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats.Geniposide inhibits high glucose-induced cell adhesion through the NF-kappaB signaling pathway in human umbilical vein endothelial cells.Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complicationsXanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.Hind limb ischemia-reperfusion injury in diet-induced obese micePeroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advancesPARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyInhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.PARP-1 modulates amyloid beta peptide-induced neuronal damage.PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade.Cardiac NO signalling in the metabolic syndrome.Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesisEarly diabetic neuropathy: triggers and mechanisms.Hypoxia-induced oxidative stress in ischemic retinopathyRole of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitorsNovel modulators of poly(ADP-ribose) polymerase.Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.Influences of Diabetes on Hearing Recovery in Noise-Exposed Mice.Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepRole of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic miceTherapeutic applications of PARP inhibitors: anticancer therapy and beyondThe role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy.Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes.Oxidative stress in diabetes: implications for vascular and other complications.Redox imbalance and mitochondrial abnormalities in the diabetic lung.Diabetic Cardiomyopathy: An Immunometabolic Perspective.Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress.
P2860
Q24645400-1D9A6ED3-C56C-47FD-A505-6063D82B6FB4Q24656109-BB014624-55DE-49A0-B3D2-28339610A97AQ26752842-259261AD-F02A-4D84-87F1-6C2FE4B27FECQ26773085-FC83F8CB-971A-49B3-B43E-9DB37344D803Q26773988-57FB8E8B-1B0F-4A54-9644-9C9D72C92FD4Q27001165-B9169F53-D299-436A-8408-EFD5E24701C0Q28076120-D9C41BB8-9550-46E6-BAEC-CB24A65BD048Q28080057-2BDDE2DA-AD4A-43EB-A9BB-ACBD152E1B86Q28547107-9D3FA567-E661-4794-9F2F-C7D56736CE11Q33270945-35976659-383B-481A-9897-4EF098F6D5C5Q33557886-26E6D9B1-6AE7-43C9-9639-BC63A4FB2A7CQ33609776-213F1391-C59E-43FE-962D-0953FEE74A2DQ33643575-B8A8A7CE-B60E-4269-83B6-54B2DC1A46E6Q33895925-100D30A2-C0F0-4E68-B2D9-BDD24BC5A5A4Q34314724-E5396DDD-68FC-4793-9FF6-13CF8A5888BFQ34670090-C61CBA8B-C553-4123-9B7C-9D50C69D4450Q34731311-F8391F07-381A-49DF-915F-4BFFE61862F5Q35004641-64BAB74C-919F-43ED-A7F6-62AE032E50B1Q35061401-617B64E9-942D-486A-B28C-FD0490477970Q35204828-1C83567E-4E1A-47D6-A13B-B7CE456BA051Q35676514-C9EC993F-687B-4FEE-BA16-48BF3E2B060AQ35676519-1D80A047-7F89-4668-982A-98B1CE72AD4EQ35691425-3CB41E80-C80E-4ABB-8ACB-6D64D638F9A9Q36355485-CC7D4F65-4F07-496D-B6E1-A37CE3EB612EQ36398989-963D5351-CFF3-4C51-A9B5-C40FA80FCF89Q36426742-58F1ADDF-9395-4DCD-AE86-2DA58A20166DQ36431798-0C175512-4F49-4E2A-8FC2-9469EED97EC2Q36431803-32EF6922-E2BB-4459-B6A5-8F2C672E7C62Q36440020-326C1771-421A-48DD-B078-FB88B832F109Q36569687-A8054992-3FD1-4805-A2CA-C333BD43B118Q36734840-BD7A8FFC-F692-4F51-A1E7-658759B6E9B4Q36791018-058DFD5D-5B69-458A-8D1A-29EF25EADED9Q36853236-D70C2205-9E63-4F37-A11D-DB8411FAD314Q36909521-75C6984F-AE73-462D-8C3F-36E86EF798FEQ37023062-4EB06FCA-DE4F-440D-9A99-D02D22ADFB5AQ37172217-A14CD75B-BC9F-4D56-8918-793A2BFC276EQ37375332-8B2CFFED-6346-45CD-8FFF-DC1AC1014983Q37442978-E7B6BE03-016B-4433-A854-2EFCE2863476Q37741735-FB307B42-18BD-4458-98F9-EEBA95759BDDQ37976675-BEE46626-1D94-4F9E-9FB8-548F9A102755
P2860
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of poly(ADP-ribose) polym ...... as a common underlying theme.
@ast
Role of poly(ADP-ribose) polym ...... as a common underlying theme.
@en
type
label
Role of poly(ADP-ribose) polym ...... as a common underlying theme.
@ast
Role of poly(ADP-ribose) polym ...... as a common underlying theme.
@en
prefLabel
Role of poly(ADP-ribose) polym ...... as a common underlying theme.
@ast
Role of poly(ADP-ribose) polym ...... as a common underlying theme.
@en
P2860
P356
P1476
Role of poly(ADP-ribose) polym ...... as a common underlying theme.
@en
P2093
Csaba Szabó
P2860
P304
P356
10.1089/ARS.2005.7.1568
P50
P577
2005-11-01T00:00:00Z